Errors in reported degrees and respondent driven sampling: Implications for bias

Drug and Alcohol Dependence

Volumn 142, Issue , 2014, Pages 120-126

  Mills, Harriet L ^a   Johnson, Samuel ^b   Hickman, Matthew ^c   Jones, Nick S ^b   Colijn, Caroline ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

At risk populations; Contact network size; Respondent driven sampling

Indexed keywords

ANALYTICAL ERROR; ARTICLE; COMPARATIVE STUDY; CORRELATIONAL STUDY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MEASUREMENT ERROR; POISSON DISTRIBUTION; PREVALENCE; PRIORITY JOURNAL; RELIABILITY; RESPONDENT DRIVEN SAMPLING; SAMPLING; SAMPLING BIAS; SAMPLING ERROR; SIMULATION; SOCIAL NETWORK; UNITED KINGDOM; EPIDEMIOLOGY; METHODOLOGY; QUESTIONNAIRE; SAMPLE SIZE; STATISTICAL BIAS; SUBSTANCE ABUSE;

BIAS (EPIDEMIOLOGY); HUMANS; PREVALENCE; RESEARCH DESIGN; SAMPLE SIZE; SAMPLING STUDIES; SUBSTANCE ABUSE, INTRAVENOUS; SURVEYS AND QUESTIONNAIRES;

EID: 84905569599     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2014.06.015     Document Type: Article

References (45)

1. Abdul-Quader A.S., Heckathorn D.D., McKnight C., Bramson H., Nemeth C., Sabin K., Gallagher K., Des Jarlais D.C. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J. Urban Health 2006, 83:459-476.
2. Bell D.C., Belli-McQueen B., Haider A. Partner naming and forgetting: recall of network members. Soc. Netw. 2007, 29:279-299.
3. Bengtsson L., Thorson A. Global HIV surveillance among MSM: is risk behavior seriously underestimated?. AIDS 2010, 24:2301-2303.
4. Brewer D.D. Forgetting in the recall-based elicitation of personal and social networks. Soc. Netw. 2000, 22:29-43.
5. Broadhead R.S., Heckathorn D.D., Altice F.L., Van Hulst Y., Carbone M., Friedland G.H., O'Connor P.G., Selwyn P.A. Increasing drug users? Adherence to HIV treatment: results of a peer-driven intervention feasibility study. Soc. Sci. Med. 2002, 55:235-246.
6. Broadhead R.S., Heckathorn D.D., Weakliem D.L., Anthony D.L., Madray H., Mills R.J., Hughes J. Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep. 1998, 113:42-57.
7. Brown N.R., Sinclair R.C. Estimating number of lifetime sexual partners: men and women do it differently. J. Sex Res. 1999, 36:292-297.
8. Burt R.D., Thiede H. Evaluating consistency in repeat surveys of injection drug users recruited by respondent-driven sampling in the Seattle area: results from the NHBS-IDU1 and NHBS-IDU2 surveys. Ann. Epidemiol. 2012, 22:354-363.
9. Degenhardt L., Mathers B., Vickerman P., Rhodes T., Latkin C., Hickman M. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet 2010, 376:285-301.
10. Des Jarlais D.C., Arasteh K., Perlis T., Hagan H., Abdul-Quader A., Heckathorn D.D., McKnight C., Bramson H., Nemeth C., Torian L.V., Friedman S.R. Convergence of HIV seroprevalence among injecting and non-injecting drug users in New York City. AIDS 2007, 21:231.
11. Fenton K.A., Johnson A.M., McManus S., Erens B. Measuring sexual behaviour: methodological challenges in survey research. Sex. Transm. Infect. 2001, 77:84-92.
12. Fisher R.J. Social desirability bias and the validity of indirect questioning. J. Consumer Res. 1993, 20:303-315.
13. Friedman S.R., Kottiri B.J., Neaigus A., Curtis R., Vermund S.H., Des Jarlais D.C. Network-related mechanisms may help explain long-term HIV-1 seroprevalence levels that remain high but do not approach population-group saturation. Am. J. Epidemiol. 2000, 152:913-922.
14. Gile K.J., Handcock M.S. Respondent-driven sampling: an assessment of current methodology. Sociol. Methodol. 2010, 40:285-327.
15. Goel S., Salganik M.J. Respondent-driven sampling as Markov chain Monte Carlo. Stat. Med. 2009, 28:2202-2229.
16. Goel S., Salganik M.J. Assessing respondent-driven sampling. Proc. Natl. Acad. Sci. USA 2010, 107:6743-6747.
17. Heckathorn D.D. Respondent-driven sampling: a new approach to the study of hidden populations. Soc. Probl. 1997, 44:174-199.
18. Heckathorn D.D. Respondent-driven sampling II: deriving valid population estimates from chain-referral samples of hidden populations. Soc. Probl. 2002, 49:11-34.
19. Heckathorn D.D. Extensions of respondent-driven sampling: analyzing continuous variables and controlling for differential recruitment. Sociol. Methodol. 2007, 37:151-207.
20. Hickman M., Hope V., Coleman B., Parry J., Telfer M., Twigger J., Irish C., Macleod J., Annett H. Assessing IDU prevalence and health consequences (HCV, overdose and drug-related mortality) in a primary care trust: implications for public health action. J. Public Health 2009, 31:374-382.
21. Hope V., Hickman M., Ngui S., Jones S., Telfer M., Bizzarri M., Ncube F., Parry J. Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots. J. Viral Hepat. 2011, 18:262-270.
22. Hope V., Hickman M., Parry J., Ncube F. Factors associated with recent symptoms of an injection site infection or injury among people who inject drugs in three English cities. Int. J. Drug Policy 2013, 25:303-307.
23. Hope V., Jeannin A., Spencer B., Gervasoni J., van de Laar M., Dubois-Arber F. Mapping HIV-related behavioural surveillance among injecting drug users in Europe, 2008. Euro Surveill. 2010, 16:977-986.
24. Iguchi M.Y., Ober A.J., Berry S.H., Fain T., Heckathorn D.D., Gorbach P.M., Heimer R., Kozlov A., Ouellet L.J., Shoptaw S., Zule W.A. Simultaneous recruitment of drug users and men who have sex with men in the United States and Russia using respondent-driven sampling: sampling methods and implications. J. Urban Health 2009, 86(Suppl. 1):5-31.
25. Johnston L.G., Malekinejad M., Kendall C., Iuppa I.M., Rutherford G.W. Implementation challenges to using respondent-driven sampling methodology for HIV biological and behavioral surveillance: field experiences in international settings. AIDS Behav. 2008, 12:131-141.
26. Liljeros F., Edling C.R., Amaral L.A.N., Stanley H.E., Aberg Y. The web of human sexual contacts. Nature 2001, 411:907-908.
27. Lu X. Linked ego networks: improving estimate reliability and validity with respondent-driven sampling. Soc. Netw. 2013, 35:669-685.
28. Malekinejad M., Johnston L.G., Kendall C., Kerr L.R.F.S., Rifkin M.R., Rutherford G.W. Using respondent-driven sampling methodology for HIV biological and behavioral surveillance in international settings: a systematic review. AIDS Behav. 2008, 12:105-130.
29. Marsden P.V. Network data and measurement. Annu. Rev. Sociol. 1990, 16:435-463.
30. Martin N.K., Vickerman P., Grebely J., Hellard M., Hutchinson S.J., Lima V.D., Foster G.R., Dillon J.F., Goldberg D.J., Dore G.J., et al. HCV treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals. Hepatology 2013, 58:1598-1609.
31. Martin N.K., Vickerman P., Hickman M. Mathematical modelling of hepatitis C treatment for injecting drug users. J. Theor. Biol. 2011, 274:58-66.
32. McCreesh N., Frost S.D.W., Seeley J., Katongole J., Tarsh M.N., Ndunguse R., Jichi F., Lunel N.L., Maher D., Johnston L.G., et al. Evaluation of respondent-driven sampling. Epidemiology 2012, 23:138-147.
33. Mills H., Colijn C., Vickerman P., Leslie D., Hope V., Hickman M. Respondent driven sampling and community structure in a population of injecting drug users, Bristol, UK. Drug Alcohol Depend. 2012, 126:324-332.
34. Newman M.E.J. The structure and function of complex networks. SIAM Rev. 2003, 45:167-256.
35. Robinson W.T., Risser J.M.H., McGoy S., Becker A.B., Rehman H., Jefferson M., Griffin V., Wolverton M., Tortu S. Recruiting injection drug users: a three-site comparison of results and experiences with respondent-driven and targeted sampling procedures. J. Urban Health 2006, 83:29-38.
36. Rudolph A.E., Fuller C.M., Latkin C. The importance of measuring and accounting for potential biases in respondent-driven samples. AIDS Behav. 2013, 17:2244-2252.
37. Rudolph A.E., Latkin C., Crawford N.D., Jones K.C., Fuller C.M. Does respondent driven sampling alter the social network composition and health-seeking behaviors of illicit drug users followed prospectively?. PLoS ONE 2011, 6:e19615.
38. Salganik M.J. Variance estimation, design effects, and sample size calculations for respondent-driven sampling. J. Urban Health 2006, 83:98-112.
39. Salganik M.J., Heckathorn D.D. Sampling and estimation in hidden populations using respondent-driven sampling. Sociol. Methodol. 2004, 34:193-240.
40. Schroder K.E., Carey M.P., Vanable P.A. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann. Behav. Med. 2003, 26:104-123.
41. Smith T.W. Discrepancies between men and women in reporting number of sexual partners: a summary from four countries. Biodemography Soc. Biol. 1992, 39:203-211.
42. Solomon S.S., Lucas G.M., Celentano D.D., Sifakis F., Mehta S.H. Beyond surveillance: a role for respondent-driven sampling in implementation science. Am. J. Epidemiol. 2013, 178:260-267.
43. Sypsa V., Paraskevis D., Malliori M., Nikolopoulos G.K., Panopoulos A., Kantzanou M., Katsoulidou A., Psichogiou M., Fotiou A., Pharris A., et al. Homelessness and other risk factors for HIV infection in the current outbreak among injection drug users in Athens, Greece. Am. J. Public Health 2014, (epub ahead of print).
44. Volz E., Heckathorn D.D. Probability based estimation theory for respondent driven sampling. J. Off. Stat. 2008, 24:79-97.
45. Wejnert C. An empirical test of respondent-driven sampling: point estimates, variance, degree measures and out of equilibrium data. Sociol. Methodol. 2009, 39:73-116.